article

1. Intravascular imaging vs. angiography alone to guide percutaneous coronary intervention in older adults: a meta-analysis of randomized controlled trials..  Coronary artery disease.  2025
2. Cumulative Burden of Geriatric Conditions and Cardiovascular Outcomes in Older Adults: Analysis From ARIC..  JACC. Advances.  -. 2025
3. Older Adults With NSTEMI: Picking the Patient's Future..  JACC. Advances.  -. 2025
4. Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older Adults..  JACC. Advances.  -. 2025
5. Toward a Universal Definition of Physical Frailty Syndrome in Older Adults With Cardiovascular Disease..  JACC. Advances.  -. 2025
6. Intracranial haemorrhage: sex, age, and treatment considerations..  Lancet (London, England).  406:1728-1729. 2025
7. Reshaping the paradigm: towards holistic cardiovascular risk assessment in older adults..  Heart (British Cardiac Society).  111:993-994. 2025
8. Clinical, economic, and health care resource utilization burden of acute myocardial infarction and the role of systemic inflammation in US hospitals: A real-world study..  American journal of preventive cardiology.  -. 2025
9. Representation of Older Adults in the AHA/ACC/HFSA Guideline for the Management of Heart Failure..  JACC. Advances.  -. 2025
10. Factors Associated with Elevated High-Sensitivity C-Reactive Protein Levels in Individuals with Atherosclerotic Cardiovascular Disease in the US and the UK..  European journal of preventive cardiology.  2025
11. The Additive Value of FFR-CT in the Evaluation of Calcified Coronary Arteries With Coronary CT Angiography..  The American journal of cardiology.  74-80. 2025
12. Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real-world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)..  Diabetes, obesity & metabolism.  27:6691-6704. 2025
13. Representation of Older Adults and Women in Randomized Trials of Noninvasive Imaging for Chest Pain..  Circulation. Cardiovascular imaging.  18:-. 2025
14. Daylight Savings Time and Acute Myocardial Infarction..  JAMA network open.  8:-. 2025
15. Global Uptake of GLP-1 Receptor Agonists in Obese, Non-Diabetic Patients with Cardiovascular Disease..  European heart journal. Quality of care & clinical outcomes.  2025
16. Older Than You Think-The Psychology of Comparison..  JAMA cardiology.  10:874-875. 2025
17. Direct Oral Anticoagulants versus Warfarin for Left Ventricular Thrombus: A Meta-Analysis of Randomized-Controlled Trials..  European journal of preventive cardiology.  2025
18. Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials..  JACC. Advances.  4:-. 2025
19. Intensive versus Less-Intensive Blood Pressure Control in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Clinical Trials..  American journal of nephrology.  1-15. 2025
20. Combined atherectomy and intravascular lithotripsy in calcified coronary lesions: a meta-analysis..  The Journal of invasive cardiology.  37. 2025
21. Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials..  Journal of the American College of Cardiology.  86:287-290. 2025
22. PCSK9 inhibitors and aging: Does chronological age matter?.  Atherosclerosis.  -. 2025
23. Healthy ageing in older adults with cardiovascular disease..  European heart journal.  46:2536-2551. 2025
24. The Impact of Cognitive Impairment on Cardiovascular Disease..  Journal of the American College of Cardiology.  85:2472-2491. 2025
25. Effect of Frailty on In-Hospital Mortality and Complications of PCI: An NCDR Registry Report..  Journal of the American College of Cardiology.  85:2416-2420. 2025
26. Systematic Review and Meta-Analysis of Dual-Layered Stents Versus Single-Layered Stents for Carotid Artery Stenosis..  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.  106:1324-1334. 2025
27. Beta-Blockers for Secondary Prevention following Myocardial Infarction in Patients Without Reduced Ejection Fraction or Heart Failure: An Updated Meta-Analysis..  European journal of preventive cardiology.  32:633-646. 2025
28. Beta-Blockers for Secondary Prevention following Myocardial Infarction in Patients Without Reduced Ejection Fraction or Heart Failure: An Updated Meta-Analysis..  European journal of preventive cardiology.  32:633-646. 2025
29. GLP-1 RA Use and Major Adverse Cardiovascular Events in Patients With Monoclonal Gammopathy of Undetermined Significance..  JAMA network open.  8:-. 2025
30. Association of age with adverse events following coronary atherectomy during percutaneous coronary intervention..  Journal of geriatric cardiology : JGC.  22:497-505. 2025
31. Moving towards precision medicine for older adults with non-ST-segment elevation myocardial infarction..  Heart (British Cardiac Society).  111:541-543. 2025
32. Contemporary Use and Clinical Significance of Initial Triple Versus Double Therapy After Percutaneous Coronary Intervention for Myocardial Infarction in Patients With Atrial Fibrillation..  Journal of the American Heart Association.  14:-. 2025
33. Development and Validation of Models to Estimate the Incident Risk of Cognitive Impairment and Atherosclerotic Cardiovascular Disease in Older Adults..  Journal of the American Heart Association.  14:-. 2025
34. TAVR vs. SAVR for severe aortic stenosis in the low and intermediate surgical risk population: An updated meta-analysis, meta-regression, and trial sequential analysis..  Cardiovascular revascularization medicine : including molecular interventions.  78-89. 2025
35. Beyond Longevity: Prioritizing Individualized Care in Older Adults With NSTE-ACS..  Journal of the American Geriatrics Society.  73:2006-2009. 2025
36. Connecting Anatomic Coronary Disease and Functional Ischemia With Treatment of Patient-Reported Angina: A Jigsaw Puzzle of Surprising Complexity..  Journal of the American College of Cardiology.  85:1754-1756. 2025
37. Anticoagulants or antiplatelets for secondary prevention of cryptogenic stroke: an updated systematic review and meta-analysis..  Heart (British Cardiac Society).  111:495-505. 2025
38. Anticoagulants or antiplatelets for secondary prevention of cryptogenic stroke: an updated systematic review and meta-analysis..  Heart (British Cardiac Society).  111:495-505. 2025
39. Healthcare Expenditure on Atrial Fibrillation in the United States: The Medical Expenditure Panel Survey 2016 to 2021..  JACC. Advances.  4:-. 2025
40. Prevent Frailty, Prevent Cardiovascular Disease: Early Identification of Patients at Risk..  JACC. Advances.  4:-. 2025
41. Population-level impact of semaglutide 2.4 mg in patients with obesity or overweight and cardiovascular disease: A modelling study based on the SELECT trial..  Diabetes, obesity & metabolism.  27:3442-3452. 2025
42. Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients: Updated Systematic Review and Network Meta-Analysis..  JACC. Advances.  4:-. 2025
43. Optical Coherence Tomography Versus Angiography Alone to Guide PCI for Complex Lesions: A Meta-Analysis of Randomized Controlled Trials..  Circulation. Cardiovascular interventions.  18:-. 2025
44. Reconsidering Pre-Procedural Fasting for Elective Percutaneous Cardiac Procedures..  Circulation. Cardiovascular interventions.  18:-. 2025
45. Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice..  Current treatment options in cardiovascular medicine.  27. 2025
46. Economic Outcomes With Precision Diagnostic Testing Versus Usual Testing in Stable Chest Pain: Results From the PRECISE Randomized Trial..  Circulation. Cardiovascular quality and outcomes.  18:-. 2025
47. Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized Trial..  Circulation. Cardiovascular quality and outcomes.  18:-. 2025
48. Invasive Strategy for Older Patients with MI..  The New England journal of medicine.  392:516-517. 2025
49. Sex differences in in-hospital outcomes and readmission rates after percutaneous coronary intervention..  Proceedings (Baylor University. Medical Center).  38:159-169. 2025
50. Stabilizing Stable Coronary Artery Disease: No Beta-Blocker, No Problem?.  JACC. Advances.  4:-. 2025
51. The DanGer of Using Age to Decide About Using Microaxial Flow Pumps in Cardiogenic Shock..  Journal of the American College of Cardiology.  85:604-605. 2025
52. Risk of Atherosclerotic Cardiovascular Disease After Chronic Obstructive Pulmonary Disease Hospitalization among Primary and Secondary Prevention Older Adults..  Journal of the American Heart Association.  14:-. 2025
53. Sex Differences in the Safety and Efficacy of Different Durations of DAPT After PCI..  JACC. Advances.  4:-. 2025
54. Beta-Blockers after Myocardial Infarction..  The New England journal of medicine.  392:-. 2025
55. Bridging Care Gaps for Older Women Undergoing Percutaneous Coronary Intervention..  Interventional cardiology clinics.  14:69-79. 2025
56. Fractional flow reserve-guided complete revascularization versus culprit-only percutaneous coronary intervention in patients with myocardial infarction: A meta-analysis of randomized controlled trials..  Cardiovascular revascularization medicine : including molecular interventions.  31-40. 2024
57. Complete revascularization versus culprit-only revascularization in older adults with ST-elevation myocardial infarction: Systematic review and meta-analysis of randomized controlled trials..  Journal of the American Geriatrics Society.  73:874-880. 2024
58. Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin-STAR frailty interest group..  Journal of the American Geriatrics Society.  73:1029-1040. 2024
59. Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Meta-Analysis..  The American journal of cardiology.  17-28. 2024
60. The Impact of Socioeconomic Status and Diagnostic Timeline on Clinical Outcomes in ATTR Cardiomyopathy..  Journal of the American College of Cardiology.  84:e289-e290. 2024
61. The Impact of Frailty on Patients With AF and HFrEF Undergoing Catheter Ablation: A Nationwide Population Study..  JACC. Advances.  3:-. 2024
62. Invasive Versus Conservative Strategy in Older Adults ≥75 Years of Age With Non-ST-segment-Elevation Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials..  Journal of the American Heart Association.  13:-. 2024
63. Healthcare Expenditure on Atrial Fibrillation in the United States: The Medical Expenditure Panel Survey 2016-2021..  medRxiv : the preprint server for health sciences.  2024
64. Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after COPD Hospitalization among Older Adults..  Annals of the American Thoracic Society.  21:1516-1523. 2024
65. Prognostic Value of Cardiovascular Biomarkers..  JAMA.  332:1302-1303. 2024
66. Validating the PREVENT Equations-A Contemporary Update to Cardiovascular Risk Assessment..  JAMA network open.  7:-. 2024
67. Cardiac adverse events after Chimeric Antigen Receptor (CAR) T cell therapies: an updated systematic review and meta-analysis..  Cardio-oncology (London, England).  10:-. 2024
68. A fiery heart: case report of perimyocarditis in a patient with eosinophilic granulomatosis with polyangiitis..  European heart journal. Case reports.  8:-. 2024
69. Comparative Analysis of PCI Strategies in Aortic Stenosis Patients Undergoing TAVI: A Systematic Review and Network Meta-Analysis..  Clinical cardiology.  47:-. 2024
70. Searching for Meaning: Refining Troponin Thresholds to Align Risks Between Spontaneous and Procedural Myocardial Infarction..  Journal of the American College of Cardiology.  84:478-481. 2024
71. Frailty and Cardiovascular Health..  Journal of the American Heart Association.  13:-. 2024
72. Percutaneous Coronary Revascularization Strategies After Myocardial Infarction: A Systematic Review and Network Meta-Analysis..  Journal of the American College of Cardiology.  84:276-294. 2024
73. Trend of Controlled Low-Density Lipoprotein Cholesterol in Older Adults With a History of Myocardial Infarction or Stroke..  JACC. Advances.  3:-. 2024
74. Representation of Older Adults in the ACC/AHA/SCAI Guideline for Coronary Artery Revascularization..  JAMA network open.  7:-. 2024
75. Frailty in the Cardiac Intensive Care Unit: Assessment and Impact..  European heart journal. Acute cardiovascular care.  13:506-514. 2024
76. Apixaban to Prevent Recurrence After Cryptogenic Stroke..  JAMA.  331:1965-1966. 2024
77. Apixaban to Prevent Recurrence After Cryptogenic Stroke..  JAMA.  331:1965-1966. 2024
78. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial..  The American journal of cardiology.  58-69. 2024
79. Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States..  Journal of the American College of Cardiology.  83:1990-1998. 2024
80. Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients..  International journal of cardiology.  -. 2024
81. Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock..  JACC. Advances.  3:-. 2024
82. Seasonal variations in admissions for atrial fibrillation or atrial flutter in the Northeast and the Midwest regions of the United States..  Proceedings (Baylor University. Medical Center).  37:560-568. 2024
83. Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series..  JACC. Cardiovascular interventions.  17:961-978. 2024
84. Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction..  Journal of clinical medicine.  13. 2024
85. Association of cardiovascular diseases with cognitive performance in older adults..  American heart journal.  10-20. 2024
86. Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis..  Journal of the Society for Cardiovascular Angiography & Interventions.  3:-. 2024
87. Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis..  JAMA network open.  7:-. 2024
88. Role of Cognitive Frailty in Older Adults With Cardiovascular Disease..  Journal of the American Heart Association.  13:-. 2024
89. Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Trials..  Journal of the American Heart Association.  13:-. 2024
90. Chronic Coronary Disease in Older Adults..  The Medical clinics of North America.  108:581-594. 2024
91. Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification..  JAMA cardiology.  9:55-62. 2024
92. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial..  The American journal of cardiology.  66-76. 2023
93. The association of timing of coronary artery bypass grafting for non-ST-elevation myocardial infarction and clinical outcomes in the contemporary United States..  Coronary artery disease.  35:261-269. 2023
94. Risk of Atherosclerotic Cardiovascular Disease Hospitalizations after COPD Hospitalization among Older Adults..  medRxiv : the preprint server for health sciences.  2023
95. The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease..  Current cardiology reports.  25:1745-1758. 2023
96. Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart disease..  Frontiers in cardiovascular medicine.  -. 2023
97. Clinical and Hemodynamic Outcomes of Balloon-Expandable Mitral Valve-in-Valve Positioning and Asymmetric Deployment: The VIVID Registry..  JACC. Cardiovascular interventions.  16:2615-2627. 2023
98. Comparative Analysis of Mortality and Amputation Rates in Patients Undergoing Atherectomy for Infra-Popliteal Peripheral Arterial Disease: Insight From the VQI..  Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.  32:-. 2023
99. Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery Disease: The PRECISE Randomized Clinical Trial..  JAMA cardiology.  8:904-914. 2023
100. Deferred Testing in Stable Outpatients With Suspected Coronary Artery Disease: A Prespecified Secondary Analysis of the PRECISE Randomized Clinical Trial..  JAMA cardiology.  8:915-924. 2023
101. Complex Percutaneous Coronary Intervention Outcomes in Older Adults..  Journal of the American Heart Association.  12:-. 2023
102. Insight Into the Optimal Timing of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Replacement..  Current problems in cardiology.  49:-. 2023
103. Life's Essential 8: Optimizing Health in Older Adults..  JACC. Advances.  2. 2023
104. Obesity and Undernutrition in Acute Myocardial Infarction..  The American journal of cardiology.  529-530. 2023
105. JACC: Advances.  JACC. Advances.  2. 2023
106. Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression..  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.  102:440-450. 2023
107. Chronic kidney disease and aortic valve replacement: Let's filter the evidence!.  Trends in cardiovascular medicine.  34:325-326. 2023
108. Delirium in older adults after percutaneous coronary intervention: Prevalence, risks, and clinical phenotypes..  Cardiovascular revascularization medicine : including molecular interventions.  60-67. 2023
109. JACC: Advances.  JACC. Advances.  2. 2023
110. Hierarchical Development of Physical Frailty and Cognitive Impairment and Their Association With Incident Cardiovascular Disease..  JACC. Advances.  2. 2023
111. Stable Coronary Artery Disease in the Age of Geriatric Cardiology..  Journal of the American College of Cardiology.  81:1710-1713. 2023
112. Carcinoid Heart Disease-Induced Right-Sided Heart Failure as a Culprit for Significant Ascites..  Case reports in gastroenterology.  17:172-177. 2023
113. Management of Stable Angina in the Older Adult Population..  Circulation. Cardiovascular interventions.  16:-. 2023
114. Doing Harm by Doing No Harm? Resisting the Urge to Retire GDMT in Older Adults With Heart Failure..  Journal of cardiac failure.  29:445-447. 2023
115. Clinical and Cost Implications of Deferred Testing in Low-risk Patients with Stable Chest Pain: A Simulation Using the PROMISE Trial..  American heart journal.  124-126. 2023
116. Trends and impact of intravascular ultrasound and optical coherence tomography on percutaneous coronary intervention for myocardial infarction..  International journal of cardiology. Heart & vasculature.  -. 2023
117. The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR..  JACC. Cardiovascular interventions.  16:189-192. 2023
118. Contemporary Weekend Effect on Management and In-Hospital Outcomes of Non-ST Elevation Myocardial Infarction..  Cardiovascular revascularization medicine : including molecular interventions.  61-62. 2023
119. Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice..  JAMA cardiology.  8:89-95. 2023
120. Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease..  Journal of the American Geriatrics Society.  71:1243-1249. 2022
121. Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction..  The American journal of cardiology.  84-92. 2022
122. Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia..  Journal of the American Geriatrics Society.  71:1034-1046. 2022
123. Deprescription of aspirin for primary prevention is uncommon at discharge in hospitalised patients with gastrointestinal bleeding..  Alimentary pharmacology & therapeutics.  57:94-102. 2022
124. Primary prevention statin therapy in older adults..  Current opinion in cardiology.  38:11-20. 2022
125. Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease..  PloS one.  17:-. 2022
126. In-hospital outcomes and readmission in older adults treated with percutaneous coronary intervention for stable ischemic heart disease..  Journal of geriatric cardiology : JGC.  19:631-642. 2022
127. Readmission and In-Hospital Outcomes After Transcatheter Aortic Valve Replacement in Patients With Dementia..  Cardiovascular revascularization medicine : including molecular interventions.  70-77. 2022
128. Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial..  American heart journal.  30-34. 2022
129. Cost-effectiveness of Pulmonary Rehabilitation Among US Adults With Chronic Obstructive Pulmonary Disease..  JAMA network open.  5:-. 2022
130. Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis..  American heart journal.  101-114. 2022
131. An age-old dilemma: Defining the optimal revascularization approach in older adults..  Journal of the American Geriatrics Society.  70:2205-2208. 2022
132. High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S..  Journal of the American College of Cardiology.  79:1802-1813. 2022
133. Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial..  Journal of cardiovascular computed tomography.  16:397-403. 2022
134. The prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization: Rationale and design of the PRECISE trial..  American heart journal.  136-148. 2021
135. Moving the Field Forward: Untangling the Impact of Frailty on Patients With Advanced Heart Failure and on Prognosticating Outcomes..  Journal of cardiac failure.  28:775-777. 2021
136. Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week..  Journal of the American College of Cardiology.  78:1550-1563. 2021
137. Rise of the Machines: Where Virtual Processing Meets Percutaneous Coronary Intervention..  The Canadian journal of cardiology.  37:1504-1506. 2021
138. Precision medicine gets an ASSIST in diagnostic testing..  European heart journal.  42:2549-2551. 2021
139. The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease..  Atherosclerosis.  1-7. 2021
140. Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?.  Journal of the American College of Cardiology.  77:268-270. 2021
141. 180-day readmission risk model for older adults with acute myocardial infarction: the SILVER-AMI study..  Open heart.  8. 2021
142. The Cumulative Impact of Chronic Stressors on Risks of Myocardial Infarction in US Older Adults..  Psychosomatic medicine.  83:987-994. 2021
143. Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events?.  The American journal of cardiology.  83-90. 2020
144. Representation of Older Adults in Cardiovascular Disease Trials Since the Inclusion Across the Lifespan Policy..  JAMA internal medicine.  180:1531-1533. 2020
145. Presentation, Treatment, and Outcomes of the Oldest-Old Patients with Acute Myocardial Infarction: The SILVER-AMI Study..  The American journal of medicine.  134:95-103. 2020
146. Teaching Old Treatments New Tricks..  Circulation. Cardiovascular interventions.  13:-. 2020
147. Prevalence, treatment, and control of severe hyperlipidemia..  American journal of preventive cardiology.  -. 2020
148. Performance of Guideline Recommendations for Prevention of Myocardial Infarction in Young Adults..  Journal of the American College of Cardiology.  76:653-664. 2020
149. Racial Differences in Long-Term Cardiovascular Outcomes: The Need to Move From Description to Action..  JACC. Cardiovascular interventions.  13:1596-1598. 2020
150. Weight change in heart failure inpatients not associated with 30-day readmission..  Future cardiology.  16:289-296. 2020
151. Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial..  JAMA cardiology.  5:193-201. 2020
152. Translating the Secondary Prevention Therapeutic Boom Into Action..  JAMA cardiology.  5:215-216. 2020
153. Predicting 6-Month Mortality for Older Adults Hospitalized With Acute Myocardial Infarction: A Cohort Study..  Annals of internal medicine.  172:12-21. 2019
154. A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention..  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.  96:E102-E109. 2019
155. The Accuracy of Cardiovascular Pooled Cohort Risk Estimates in U.S. Older Adults..  Journal of general internal medicine.  35:1701-1708. 2019
156. Sex-Based Differences in Presentation, Treatment, and Complications Among Older Adults Hospitalized for Acute Myocardial Infarction: The SILVER-AMI Study..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
157. Sex Differences in the Use of Statins in Community Practice..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
158. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts..  Journal of the American Geriatrics Society.  67:2560-2567. 2019
159. Highlights From the American Heart Association's EPI|LIFESTYLE 2019 Scientific Sessions..  Journal of the American Heart Association.  8:-. 2019
160. Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry..  American heart journal.  113-124. 2019
161. Thirty-Day Readmission Risk Model for Older Adults Hospitalized With Acute Myocardial Infarction..  Circulation. Cardiovascular quality and outcomes.  12:-. 2019
162. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry..  JAMA cardiology.  3:739-748. 2018
163. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry..  Journal of the American Heart Association.  7. 2018
164. Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study)..  Circulation. Heart failure.  11:-. 2018
165. Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry..  Circulation. Cardiovascular quality and outcomes.  11:-. 2018
166. Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina..  Journal of thrombosis and thrombolysis.  44:303-315. 2017
167. Carotid artery stenting versus carotid endarterectomy..  Postgraduate medical journal.  92:532-9. 2016
168. Emergent pacemaker placement in a patient with Lyme carditis-induced complete heart block and ventricular asystole..  BMJ case reports.  2016
169. Physicians' perceptions of the Thrombolysis in Myocardial Infarction (TIMI) risk score in older adults with acute myocardial infarction..  Heart & lung : the journal of critical care.  44:376-81. 2015
170. Risk Stratification in Older Patients With Acute Myocardial Infarction: Physicians' Perspectives..  Journal of aging and health.  28:387-402. 2015
171. Pregnancy complicated by valvular heart disease: an update..  Journal of the American Heart Association.  3:-. 2014